Koers Epirus Biopharmaceuticals Inc Other OTC
Aandelen
US29428P1075
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,66 | Marktkapitalisatie | 75,33 mln. 70,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -38,39 mln. | Nettowinst (verlies) 2015 | -52 mln. -48,69 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,28 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,62 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,13% | 52,73 mld. | |
+37,49% | 39 mld. | |
-8,73% | 38,52 mld. | |
+28,09% | 30,38 mld. | |
-12,26% | 26,39 mld. | |
+10,57% | 26,08 mld. | |
+45,05% | 14,15 mld. | |
+32,23% | 12,6 mld. | |
-6,56% | 11,51 mld. |